These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 661563
1. Effect of pyridoxine on the depletion of tissue pyridoxal phosphate by carbidopa. Airoldi L, Watkins CJ, Wiggins JF, Wurtman RJ. Metabolism; 1978 Jul; 27(7):771-9. PubMed ID: 661563 [No Abstract] [Full Text] [Related]
2. [Effect of VB6 on L-DOPA decarboxylase activity in the organs of rats given peripheral L-DOPA decarboxylase inhibitors (author's transl)]. Yoshimine N, Kuzuya F, Mori K, Sakamoto N. Nihon Ronen Igakkai Zasshi; 1978 Nov; 15(6):566-73. PubMed ID: 732010 [No Abstract] [Full Text] [Related]
3. Effect of carbidopa on the metabolism of L-dopa in the pigtail monkey. Bronaugh RL, Wenger GR, Garver DL, Rutledge CO. Biochem Pharmacol; 1976 Jul 15; 25(14):1679-81. PubMed ID: 821489 [No Abstract] [Full Text] [Related]
4. On the mechanism of the nullification of CNS effects of L-DOPA by pyridoxine in Parkinsonian patients. Pfeiffer R, Ebadi M. J Neurochem; 1972 Sep 15; 19(9):2175-81. PubMed ID: 5072392 [No Abstract] [Full Text] [Related]
5. Relationships between pyridoxal phosphate availability, activity of vitamin B 6 -dependent enzymes and convulsions. Tapia R, Pasantes H. Brain Res; 1971 Jun 04; 29(1):111-22. PubMed ID: 5564253 [No Abstract] [Full Text] [Related]
6. A comparison of the effects of decarboxylase inhibitors on L-dopa-induced circling behavior and the conversion of dopa to dopamine in the brain. Goodale DB, Moore KE. Life Sci; 1976 Sep 01; 19(5):701-6. PubMed ID: 957902 [No Abstract] [Full Text] [Related]
10. Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers. Da Prada M, Kettler R, Zürcher G, Schaffner R, Haefely WE. Eur Neurol; 1987 Sep 01; 27 Suppl 1():9-20. PubMed ID: 3123242 [Abstract] [Full Text] [Related]
12. Studies on the enzymatic blood-brain barrier: quantitative measurements of DOPA decarboxylase in the wall of microvessels as related to the parenchyma in various CNS regions. Hardebo JE, Falck B, Owman C, Rosengren E. Acta Physiol Scand; 1979 Apr 01; 105(4):453-60. PubMed ID: 452922 [Abstract] [Full Text] [Related]
15. Chlorpromazine-induced accumulation of pyridoxal-5'-phosphate and activation of the decarboxylase of aromatic amino acids in rat brain. Gey KF, Burkard WP. Ann N Y Acad Sci; 1969 Sep 30; 166(1):213-24. PubMed ID: 5308031 [No Abstract] [Full Text] [Related]
16. Carbidopa elevates hypothalamic dopa and serum prolactin in rats. Watkins CJ, Wiggins JF, Wurtman RJ. Life Sci; 1979 Apr 30; 24(18):1675-82. PubMed ID: 481101 [No Abstract] [Full Text] [Related]
19. Suppression of noradrenaline synthesis in sympathetic nerves by carbidopa, an inhibitor of peripheral dopa decarboxylase. Wurtman RJ, Watkins CJ. Nature; 1977 Jan 06; 265(5589):79-80. PubMed ID: 834247 [No Abstract] [Full Text] [Related]
20. Effect of high single doses of levodopa and carbidopa on brain dopamine and its metabolites: modulation by selective inhibitors of monoamine oxidase and/or catechol-O-methyltransferase in the male rat. Männistö PT, Tuomainen P. Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct 06; 344(4):412-8. PubMed ID: 1766471 [Abstract] [Full Text] [Related] Page: [Next] [New Search]